Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (561-570 of 635) with videos related to

Pageof 64
Sort By:
BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.
European Urology|October 2, 2012
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient careOsamu Ukimura, Jonathan A Coleman, Alex de la Taille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2011
ERG gene rearrangements are common in prostatic small cell carcinomasTamara L Lotan, Nilesh S Gupta, Wenle Wang, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Human Pathology|December 3, 2014
Utility of uroplakin II expression as a marker of urothelial carcinomaWei Tian, Gunes Guner, Hiroshi Miyamoto, et al.
The Prostate|July 11, 2020
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significanceHarsimar Kaur, Iryna Samarska, Jiayun Lu, et al.
CA: a Cancer Journal for Clinicians|June 9, 2016
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemLysandra Voltaggio, Ashley Cimino-Mathews, Justin A Bishop, et al.
The American Journal of Surgical Pathology|December 18, 2014
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsyCarlos L Morais, Jeong S Han, Jennifer Gordetsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Pageof 64

Showing results (561-570 of 635) with videos related to

Sort By:
Pageof 64
BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.
European Urology|October 2, 2012
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient careOsamu Ukimura, Jonathan A Coleman, Alex de la Taille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2011
ERG gene rearrangements are common in prostatic small cell carcinomasTamara L Lotan, Nilesh S Gupta, Wenle Wang, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Human Pathology|December 3, 2014
Utility of uroplakin II expression as a marker of urothelial carcinomaWei Tian, Gunes Guner, Hiroshi Miyamoto, et al.
The Prostate|July 11, 2020
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significanceHarsimar Kaur, Iryna Samarska, Jiayun Lu, et al.
CA: a Cancer Journal for Clinicians|June 9, 2016
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemLysandra Voltaggio, Ashley Cimino-Mathews, Justin A Bishop, et al.
The American Journal of Surgical Pathology|December 18, 2014
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsyCarlos L Morais, Jeong S Han, Jennifer Gordetsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Pageof 64